Roger Barker (Former)
1 – 130 of 130
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
The annotation of GBA1 has been concealed by its protein-coding pseudogene GBAP1
(
- Contribution to journal › Article
-
Mark
The history and status of dopamine cell therapies for Parkinson's disease
2024) In BioEssays(
- Contribution to journal › Scientific review
-
Mark
The basal forebrain cholinergic system as target for cell replacement therapy in Parkinson's disease
(
- Contribution to journal › Scientific review
- 2023
-
Mark
Restorative cell and gene therapies for Parkinson's disease
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD
(
- Contribution to journal › Article
-
Mark
LINE-1 retrotransposons drive human neuronal transcriptome complexity and functional diversification
(
- Contribution to journal › Article
- 2022
-
Mark
Distinct subcellular autophagy impairments in induced neurons from patients with Huntington's disease
(
- Contribution to journal › Article
-
Mark
Age-related pathological impairments in directly reprogrammed dopaminergic neurons derived from patients with idiopathic Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Single-cell transcriptional and functional analysis of dopaminergic neurons in organoid-like cultures derived from human fetal midbrain
(
- Contribution to journal › Article
-
Mark
Hunting out the autophagic problem in Huntington disease
(
- Contribution to journal › Debate/Note/Editorial
- 2021
-
Mark
A quantitative model of cellular decision making in direct neuronal reprogramming
(
- Contribution to journal › Article
-
Mark
Reprogramming human adult fibroblasts into GABAergic interneurons
(
- Contribution to journal › Article
-
Mark
Stem Derived Dopamine Neurons : Will They Replace DBS as the Leading Neurosurgical Treatment for Parkinson's Disease?
(
- Contribution to journal › Article
- 2020
-
Mark
Parkinson’s disease laterality : a 11C-PE2I PET imaging study
2020) In Journal of Neurology(
- Contribution to journal › Article
-
Mark
Animal Models of Parkinson's Disease : Are They Useful or Not?
(
- Contribution to journal › Scientific review
-
Mark
Longitudinal functional connectivity changes related to dopaminergic decline in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
3D-Printed Soft Lithography for Complex Compartmentalized Microfluidic Neural Devices
(
- Contribution to journal › Article
-
Mark
GDNF and Parkinson's Disease : Where Next? A Summary from a Recent Workshop
(
- Contribution to journal › Article
- 2019
-
Mark
Designing stem-cell-based dopamine cell replacement trials for Parkinson’s disease
(
- Contribution to journal › Article
-
Mark
Dual modulation of neuron-specific microRNAs and the REST complex promotes functional maturation of human adult induced neurons
(
- Contribution to journal › Article
-
Mark
Exploring causality of the association between smoking and Parkinson's disease
(
- Contribution to journal › Article
- 2018
-
Mark
Dermal fibroblasts from patients with Parkinson's disease have normal GCase activity and autophagy compared to patients with PD and GBA mutations
(
- Contribution to journal › Article
-
Mark
Simple Generation of a High Yield Culture of Induced Neurons from Human Adult Skin Fibroblasts
(
- Contribution to journal › Article
-
Mark
11C-PE2I and 18F-Dopa PET for assessing progression rate in Parkinson's : A longitudinal study
(
- Contribution to journal › Article
-
Mark
New approaches for brain repair-from rescue to reprogramming
(
- Contribution to journal › Scientific review
-
Mark
Huntingtin Aggregation Impairs Autophagy, Leading to Argonaute-2 Accumulation and Global MicroRNA Dysregulation
(
- Contribution to journal › Article
- 2017
-
Mark
Neuroendocrine abnormalities in Parkinson's disease
(
- Contribution to journal › Scientific review
-
Mark
Motor associations of iron accumulation in deep grey matter nuclei in Parkinson's disease : A cross-sectional study of iron-related magnetic resonance imaging susceptibility
(
- Contribution to journal › Article
-
Mark
Human Trials of Stem Cell-Derived Dopamine Neurons for Parkinson's Disease : Dawn of a New Era
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Strategies for bringing stem cell-derived dopamine neurons to the clinic : A European approach (STEM-PD)
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
REST suppression mediates neural conversion of adult human fibroblasts via microRNA-dependent and -independent pathways
(
- Contribution to journal › Article
-
Mark
Direct neuronal reprogramming for disease modeling studies using patient-derived neurons : What have we learned?
(
- Contribution to journal › Scientific review
-
Mark
GFORCE-PD still going strong in 2016
(
- Contribution to journal › Scientific review
- 2016
-
Mark
GSK-3β-induced Tau pathology drives hippocampal neuronal cell death in Huntington's disease : involvement of astrocyte-neuron interactions
(
- Contribution to journal › Article
-
Mark
Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's
(
- Contribution to journal › Article
-
Mark
Regional expression of the MAPT gene is associated with loss of hubs in brain networks and cognitive impairment in Parkinson disease and progressive supranuclear palsy
(
- Contribution to journal › Article
-
Mark
Equating scores of the University of Pennsylvania Smell Identification Test and Sniffin' Sticks test in patients with Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Molecular Diversity of Midbrain Development in Mouse, Human, and Stem Cells
(
- Contribution to journal › Article
-
Mark
Statins are underused in recent-onset Parkinson's disease with increased vascular risk : findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts
(
- Contribution to journal › Article
-
Mark
α-Synuclein pre-formed fibrils impair tight junction protein expression without affecting cerebral endothelial cell function
(
- Contribution to journal › Article
-
Mark
A PBX1 transcriptional network controls dopaminergic neuron development and is impaired in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Making it personal : the prospects for autologous pluripotent stem cell-derived therapies
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Atomoxetine restores the response inhibition network in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Learning to be inflexible : Enhanced attentional biases in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Exogenous melatonin for Parkinson's disease: 'Waking up' to the need for further trials
(
- Contribution to journal › Letter
-
Mark
Setting Global Standards for Stem Cell Research and Clinical Translation : The 2016 ISSCR Guidelines
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Aberrant nigral diffusion in Parkinson's disease : A longitudinal diffusion tensor imaging study
(
- Contribution to journal › Article
-
Mark
Cognitive decline and quality of life in incident Parkinson's disease : The role of attention
(
- Contribution to journal › Article
-
Mark
Time on timing : Dissociating premature responding from interval sensitivity in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Deletions at 22q11.2 in idiopathic Parkinson's disease : a combined analysis of genome-wide association data
(
- Contribution to journal › Article
-
Mark
Variation in Recent Onset Parkinson's Disease : Implications for Prodromal Detection
(
- Contribution to journal › Article
-
Mark
Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD)
(
- Contribution to journal › Article
-
Mark
The neurology community mourns the passing of Dr. John F. Kurtzke
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Hypothalamic volume loss is associated with reduced melatonin output in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Development and external validation of a prognostic model in newly diagnosed Parkinson disease
(
- Contribution to journal › Article
-
Mark
Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures
(
- Contribution to journal › Article
-
Mark
Characterization and Visualization of Vesicles in the Endo-Lysosomal Pathway with Surface-Enhanced Raman Spectroscopy and Chemometrics
(
- Contribution to journal › Article
-
Mark
Hippocampal dysfunction defines disease onset in Huntington's disease
(
- Contribution to journal › Article
-
Mark
Different decision deficits impair response inhibition in progressive supranuclear palsy and Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Advancing pharmacotherapy for treating Huntington's disease : a review of the existing literature
(
- Contribution to journal › Article
-
Mark
Comparative epidemiology of incident Parkinson's disease in Cambridgeshire, UK
(
- Contribution to journal › Article
-
Mark
A simple assessment model to quantifying the dynamic hippocampal neurogenic process in the adult mammalian brain
(
- Contribution to journal › Article
-
Mark
Gray and white matter imaging : A biomarker for cognitive impairment in early Parkinson's disease?
(
- Contribution to journal › Article
-
Mark
Are Stem Cell-Based Therapies for Parkinson's Disease Ready for the Clinic in 2016?
(
- Contribution to journal › Article
-
Mark
Comparability : Manufacturing, characterization and controls, report of a UK Regenerative Medicine Platform Pluripotent Stem Cell Platform Workshop, Trinity Hall, Cambridge, 14-15 September 2015
(
- Contribution to journal › Article
-
Mark
Increased serotonin-to-dopamine transporter ratios in Parkinson disease dyskinesias: a longitudinal study
(
- Contribution to conference › Abstract
- 2015
-
Mark
Cell-based therapies for Parkinson disease-past insights and future potential.
(
- Contribution to journal › Scientific review
-
Mark
The role of tau in the pathological process and clinical expression of Huntington's disease
(
- Contribution to journal › Article
-
Mark
Cerebrovascular and blood-brain barrier impairments in Huntington's disease : Potential implications for its pathophysiology
(
- Contribution to journal › Article
-
Mark
Dopamine and Huntington's disease
(
- Contribution to journal › Article
-
Mark
A novel combinational approach of microstimulation and bioluminescence imaging to study the mechanisms of action of cerebral electrical stimulation in mice
(
- Contribution to journal › Article
-
Mark
Toll-like receptor expression in the blood and brain of patients and a mouse model of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Anticholinergic Load : Is there a Cognitive Cost in Early Parkinson's Disease?
(
- Contribution to journal › Article
-
Mark
Novel Nut and Bolt Task Quantifies Motor Deficits in Premanifest and Manifest Huntington's Disease
(
- Contribution to journal › Article
-
Mark
Tracking Parkinson's : Study Design and Baseline Patient Data
(
- Contribution to journal › Article
-
Mark
Rating Apathy in Huntington’s Disease : Patients and Companions Agree
(
- Contribution to journal › Article
-
Mark
Antidopaminergic Medication is Associated with More Rapidly Progressive Huntington's Disease
(
- Contribution to journal › Article
-
Mark
Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease : ICICLE-PD study
(
- Contribution to journal › Article
-
Mark
Sleep deficits but no metabolic deficits in premanifest Huntington's disease
(
- Contribution to journal › Article
-
Mark
Gaucher disease and comorbidities : B-cell malignancy and parkinsonism
(
- Contribution to journal › Scientific review
-
Mark
Progress in Huntington's disease : the search for markers of disease onset and progression
(
- Contribution to journal › Article
-
Mark
The role of the amygdala during emotional processing in Huntington's disease : from pre-manifest to late stage disease
(
- Contribution to journal › Article
-
Mark
Retrospective assessment of movement disorder society criteria for mild cognitive impairment in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
The effect of multidisciplinary rehabilitation on brain structure and cognition in Huntington's disease : an exploratory study
(
- Contribution to journal › Article
-
Mark
Association between MAPT haplotype and memory function in patients with Parkinson's disease and healthy aging individuals
(
- Contribution to journal › Article
-
Mark
Improving response inhibition in Parkinson's disease with atomoxetine
(
- Contribution to journal › Article
- 2014
-
Mark
Stem cell therapies for Parkinson's disease : are trials just around the corner?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Developing stem cell therapies for Parkinson's disease : waiting until the time is right
(
- Contribution to journal › Article
-
Mark
Prediction of manifest Huntington's disease with clinical and imaging measures : a prospective observational study
(
- Contribution to journal › Article
-
Mark
'The clocks that time us'--circadian rhythms in neurodegenerative disorders
(
- Contribution to journal › Scientific review
-
Mark
Molecular and functional definition of the developing human striatum
(
- Contribution to journal › Article
-
Mark
The Central Clock in Patients With Parkinson Disease — Reply
(
- Contribution to journal › Letter
-
Mark
Which patients with Parkinson's disease participate in clinical trials? : One centre's experiences with a new cell based therapy trial (TRANSEURO)
(
- Contribution to journal › Article
-
Mark
Mild cognitive impairment and Parkinson's disease - something to remember
(
- Contribution to journal › Article
-
Mark
Modelling of a targeted nanotherapeutic 'stroma' to deliver the cytokine LIF, or XAV939, a potent inhibitor of Wnt-β-catenin signalling, for use in human fetal dopaminergic grafts in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease : ICICLE-PD study
(
- Contribution to journal › Article
-
Mark
Neurodegenerative disorders : the Glia way forward
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Targeting impulsivity in Parkinson's disease using atomoxetine
(
- Contribution to journal › Article
-
Mark
Mutant huntingtin is present in neuronal grafts in Huntington disease patients
(
- Contribution to journal › Article
-
Mark
The phosphorylation status of Ascl1 is a key determinant of neuronal differentiation and maturation in vivo and in vitro
(
- Contribution to journal › Article
-
Mark
Sleep and circadian rhythm regulation in early Parkinson disease
(
- Contribution to journal › Article
-
Mark
The spectrum of cognitive impairment in Lewy body diseases
(
- Contribution to journal › Scientific review
-
Mark
Severity of mild cognitive impairment in early Parkinson's disease contributes to poorer quality of life
(
- Contribution to journal › Article
-
Mark
Treating Parkinson's disease in the 21st century : can stem cell transplantation compete?
(
- Contribution to journal › Article
-
Mark
Anti-amyloid compounds inhibit α-synuclein aggregation induced by protein misfolding cyclic amplification (PMCA)
(
- Contribution to journal › Article
-
Mark
The glial response to intracerebrally delivered therapies for neurodegenerative disorders : is this a critical issue?
(
- Contribution to journal › Scientific review
-
Mark
Quality of life and mild cognitive impairment in early Parkinson's disease : does subtype matter?
(
- Contribution to journal › Article
-
Mark
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease : a dose escalation, open-label, phase 1/2 trial
(
- Contribution to journal › Article
-
Mark
Gold nanoparticles explore cells : cellular uptake and their use as intracellular probes
(
- Contribution to journal › Article
-
Mark
Characterizing mild cognitive impairment in incident Parkinson disease : the ICICLE-PD study
(
- Contribution to journal › Article
-
Mark
Selective serotonin reuptake inhibition modulates response inhibition in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
A retrospective analysis of hand tapping as a longitudinal marker of disease progression in Huntington's disease
(
- Contribution to journal › Article
-
Mark
Time course of dopamine neuron loss and glial response in the 6-OHDA striatal mouse model of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Neurodegenerative disease : Mapping the natural history of Huntington disease
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Predictors of Parkinson's disease dementia : towards targeted therapies for a heterogeneous disease
(
- Contribution to journal › Article
-
Mark
Health-related quality of life in early Parkinson's disease : the impact of nonmotor symptoms
(
- Contribution to journal › Article
-
Mark
The incidence of Parkinson's disease in the North-East of England
(
- Contribution to journal › Article
- 2013
-
Mark
Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease
(
- Contribution to journal › Scientific review
-
Mark
Efficient expansion and dopaminergic differentiation of human fetal ventral midbrain neural stem cells by midbrain morphogens
(
- Contribution to journal › Article
-
Mark
The challenges of administering cell-based therapies to patients with Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Linked clinical trials - the development of new clinical learning studies in Parkinson's disease using screening of multiple prospective new treatments
(
- Contribution to journal › Article
-
Mark
The Addenbrooke's Cognitive Examination-Revised accurately detects cognitive decline in Huntington's disease
(
- Contribution to journal › Article
-
Mark
Personality affects aspects of health-related quality of life in Parkinson's disease via psychological coping strategies
(
- Contribution to journal › Article
-
Mark
The relationship between abnormalities of saccadic and manual response times in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
The CamPaIGN study of Parkinson's disease : 10-year outlook in an incident population-based cohort
(
- Contribution to journal › Article
- 2012
-
Mark
Parkinson's Disease in a Dish : What Patient Specific-Reprogrammed Somatic Cells Can Tell Us about Parkinson's Disease, If Anything?
(
- Contribution to journal › Article
- 2010
-
Mark
Neural grafting in Parkinson's disease: problems and possibilities
(
- Contribution to journal › Scientific review
- 2003
-
Mark
Neural transplantation for the treatment of Parkinson's disease
(
- Contribution to journal › Debate/Note/Editorial
- 2000
-
Mark
Neural tissue xenotransplantation : What Is Needed Prior to Clinical Trials in Parkinson’s Disease?
(
- Contribution to journal › Article